Cargando…
Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses
Recurrent outbreaks of novel zoonotic coronavirus (CoV) diseases in recent years have highlighted the importance of developing therapeutics with broad-spectrum activity against CoVs. Because all CoVs use −1 programmed ribosomal frameshifting (−1 PRF) to control expression of key viral proteins, the...
Autores principales: | Munshi, Sneha, Neupane, Krishna, Ileperuma, Sandaru M., Halma, Matthew T. J., Kelly, Jamie A., Halpern, Clarissa F., Dinman, Jonathan D., Loerch, Sarah, Woodside, Michael T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876150/ https://www.ncbi.nlm.nih.gov/pubmed/35215770 http://dx.doi.org/10.3390/v14020177 |
Ejemplares similares
-
Anti-Frameshifting Ligand Active against SARS Coronavirus-2 is Resistant to Natural Mutations of the Frameshift-Stimulatory Pseudoknot
por: Neupane, Krishna, et al.
Publicado: (2021) -
Anti-Frameshifting Ligand Active against SARS Coronavirus-2 Is Resistant to Natural Mutations of the Frameshift-Stimulatory Pseudoknot
por: Neupane, Krishna, et al.
Publicado: (2020) -
Structural and functional conservation of the programmed −1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2)
por: Kelly, Jamie A., et al.
Publicado: (2020) -
Programmed −1 Ribosomal Frameshifting in coronaviruses: A therapeutic target
por: Kelly, Jamie A., et al.
Publicado: (2021) -
Structural and functional conservation of the programmed −1 ribosomal frameshift signal of SARS-CoV-2
por: Kelly, Jamie A., et al.
Publicado: (2020)